SKI Market

A+| A| A-|

Indian Indices

Sensex

75,508.54 899.56
( 1.21%)

Global Indices

Nasdaq

49,714.12 -67.45
(-0.14%)

Dow Jones

7,466.35 44.39
(0.60%)

Hang Seng

62,791.91 -480.20
(-0.76%)

Nikkei 225

10,300.99 35.67
(0.35%)

Forex

USD-INR

95.60 0.47
(0.49%)

EUR-INR

112.29 0.30
(0.26%)

GBP-INR

129.50 0.02
(0.02%)

JPY-INR

0.61 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

375.7898972

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

32.79

105592.45

EPS(TTM)

Face Value()

Div & Yield %

38.58

0.63

Back

global education ltd

Board of Minda Corporation recommends Interim Dividend

Feb 05,2026

Minda Corporation announced that the Board of Directors of the Company at its meeting held on 05 February 2026, has recommended a Interim Dividend of Rs.0.60 per share (i.e.30%), subject to the approval of the shareholders.

75,508.54 899.56 ( 1.21%)

49,714.12 -67.45 (-0.14%)

7,466.35 44.39 (0.60%)

62,791.91 -480.20 (-0.76%)

10,300.99 35.67 (0.35%)

95.60 0.47 (0.49%)

112.29 0.30 (0.26%)

129.50 0.02 (0.02%)

0.61 0.00 (0.19%)